Yingzi Xu, Ph.D.
Associate Director, Medicinal Chemistry
Dr. Xu has 14 years of pharmaceutical industrial experience in the field of medicinal chemistry. Prior to joining Terns Pharma, she was a principal scientist at Elan Pharmaceuticals, where she served as project team leader for the small molecule BACE inhibitor project for the treatment of Alzheimer’s disease.
Dr. Xu received her Ph.D. in Chemistry from Columbia University and completed her postdoctoral research at University of California, Berkeley.